FORM OF REGISTRATION RIGHTS AGREEMENT
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 19, 2005, by
and between CORGENIX MEDICAL CORPORATION, a Nevada corporation (the “Company”), and
[[PURCHASERS] (the “Purchasers”).
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, by
and between the Purchasers and the Company (as amended, modified or supplemented from time to time, the
“Securities Purchase Agreement”), and pursuant to the Notes and the Warrants referred to therein.
The Company and the Purchasers hereby agree as follows:
1. Definitions . Capitalized terms used and not otherwise defined herein that are defined in the
Securities Purchase Agreement shall have the meanings given such terms in the Securities Purchase Agreement.
As used in this Agreement, the following terms shall have the following meanings:
“ Commission ” means the Securities and Exchange Commission.
“ Common Stock ” means shares of the Company’s common stock, par value $0.001 per share.
“ Effectiveness Date ” means (i) with respect to the initial Registration Statement required to be
filed hereunder, a date no later than one-hundred-twenty (120) days following the date hereof and (ii) with
respect to each additional Registration Statement required to be filed hereunder, a date no later than forty (40)
days following the applicable Filing Date.
“ Effectiveness Period ” shall have the meaning set forth in Section 2(a).
“ Exchange Act ” means the Securities Exchange Act of 1934, as amended, and any successor
“ Filing Date ” means, (i) with respect to the initial Registration Statement required to be filed
hereunder, a date no later than thirty (30) days following the date hereof, and (ii) with respect to shares of
Common Stock issuable to the Holder as a result of adjustments to the Fixed Conversion Price made pursuant to